NEW YORK, March 16 (GenomeWeb News) - DiaGenic, a Norwegian in vitro diagnostics company that has been developing a test for early breast cancer based on microarray platforms, said last week that it is looking for a chip vendor to help it develop and eventually launch the product.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.